Looking at the "Henan path" of accelerating the rise of the biomedical industry from the Azf Fixed Piece Industry Chain

Editor's note: In the recent time, Azf's fixed film, as the first domestic anti -new crown oral medication, has attracted much attention. On August 2, Azf's fixed film was officially put into production in Pingdingshan, Henan, marking the development of a new chapter in the development of the biomedical industry in Henan Province. The victory over the new crown pneumonia contributed the "Chinese power".

From now on, Elephant News will launch a series of "Henan" Medicine "self -improvement, focusing on hot issues that the public cares about and pay attention to the development of the development of the biomedical industry in Henan. Today, the third article "The" Henan Path "of the Rising Rise of the Biomedical Industry from the Azf Fixed Piece Industry" was launched.

Elephant reporter Wang Lin

In the modern biomedical production workshop of Xinxiang Pharmaceutical Co., Ltd., the raw medicine of Azf's fixed slices is accelerating production. As my country's first self -developed anti -new crown oral small molecular drug, the Azf of Henan Real Biotechnology Co., Ltd. is ready to be listed. Although it is a new medicine, the entire industrial chain of Azf has the basic conditions for landing Henan. In this regard, relevant industry insiders said that the reason why it is so fast is inseparable from the rapid rise of the biomedical industry in Henan in recent years. As one of the emerging industries cultivated by Henan, how is the development of the biomedical industry in Henan, and how does it become a "new kinetic energy" for steady growth in accelerating the rise?

From the innovation chain to the industrial chain Azf fixed film all the industry chain

On August 2nd, Henan Real Biotechnology Co., Ltd. held the "New Crown Oral Medicine Azf Fixed Substation Ceremony" in Pingdingshan. This ceremony symbolized that Azf's fixed film officially entered the production stage.

At the same time, the reporter learned from the Provincial Drug Administration that as a new drug, Azf's fixed film, from R & D, raw medicine production, preparation production to sales headquarters and other industrial chains have already had the basic conditions for landing Henan.

The complete formation of a new drug industry chain must go through many links, and the reason why Azf's fixed industry chain can be formed quickly in Henan is because of the industry's opinion because of the foundation and advantages of Henan biomedical industry. Especially in recent years, the scale of the industry has continued to expand, the results of innovation are significant, and the development of the biomedical industry is thousands of miles.

"Henan's biomedical industry itself has a certain foundation, and has developed very quickly in recent years." Wang Yunlong, director of the Henan Provincial Biological Engineering Technology Research Center, provincial government counselor, Central Plains scholars, and major special scientist in Henan Province, Henan Province, Henan The independently developed China's first anti -new crown "special effects medicine" Azf's fixed film was recently approved to be listed, injecting new impetus and vitality into the development of Henan biomedical industry.

As an inventor of Azf, Henan Normal University professor, Chang Junbiao, deputy secretary and vice president of Zhengzhou University Party Committee, believes that "on the one hand, Henan attaches importance to the introduction and training of talents, and on the other hand, Henan's strong support for technical projects, and then Coupled with a loose policy, this provides a good foundation for the development of the biomedical industry to empower the biomedical industry. "

Henan's forward -looking layout uses biotechnology as one of the future leading industries

From the perspective of the industry, from the innovation chain to the industrial chain, the landing of Azf's fixed -chip industry chain marks the iconic breakthrough of Henan Province's implementation of innovation -driven, science and education province, and talent -strong provincial strategy.

In fact, Henan has regarded biotechnology as a strategic emerging industry. At the end of last year, the "Fourteenth Five -Year Plan" strategic emerging industry and future industrial development plan "was officially issued and implemented. The industry's prospective layout is one of the four leading industries.

The development of the biomedical industry has a unique advantage in Henan. The resources of Chinese medicinal materials are rich and the industrial foundation is solid. After years of development, the advantages of the biomedical industry have gradually begun to appear. From the perspective of resource endowment, the data shows that at present, the production and planting area of ​​Henan's Chinese medicinal materials ranks among the top 3 in the country. Especially in recent years, the planting area of ​​Chinese medicinal materials in the province has continued to climb from 4 million mu to 5 million mu. Like the Danshen and Buple Mountain, Huaishan Yaoshan, Huaidi Yellow, Yaoshan's Yuzhu, Mao Cangshu, Atractylodes, etc., are all monuments in the industry.

Wang Yunlong said that in recent years, Henan has focused on a series of measures such as deepening open cooperation, creating superior brands, providing innovation platforms, and building a full industrial chain system. Good, and the strength is significantly enhanced.

The development of the biomedical industry Henan not only has the foundation but also advantages

According to data from the Henan Provincial Department of Industry and Information Technology, there are more than 500 pharmaceutical industry enterprises above the designated size of Henan, with a total output value of 285.8 billion yuan, and the industrial scale ranks 5th in the country. The field has strong competitiveness.

The reporter learned that in addition to real creatures, in recent years, Henan has also cultivated a group of leading enterprises in the development of the biomedical industry, such as Hualan Biology, Antu Biology, Lingrui Pharmaceutical, and Tailong Pharmaceutical. "The diagnostic reagents of Antu Biological, the vaccine of Hualan creatures, etc., are all leading in the country." Wang Yunlong introduced that in the field of small -capacity injections, Zhengzhou led the whole country with an annual production capacity of 8 billion yuan, occupying the national market A quarter of the share.

Not only are leading companies, in recent years, the degree of agglomeration of the biomedical industry in Henan has also increased. The reporter learned in an interview that at present, Henan has formed a development pattern of supporting support for Zhengzhou and Xinxiang Biomedical Bases, as well as the development pattern of Nanyang, Anyang, and Zhumadian, which constitutes the main force of the development of the biomedical industry in Henan. "Like Xinxiang and Zhengzhou biomedicine, Nanyang's Chinese medicine, Anyang and Zhumadian's antibiotics, etc., from the perspective of the country, they have a certain scale and influence." Wang Yunlong said.

Taking Zhengzhou Linkong Biopharmaceutical Park located in Zhengzhou Airport Experimental Zone as an example, as the primary carrier of the "National High -tech Biological Industry Base", the park brings together many industries such as Chuangmai Biological, Zhengzhou Shengsi, Tai Kihong Nuo A group of international leading new drugs for tumor, hepatitis, diabetes, pulmonary hypertension and other major categories of major and malignant diseases have been initially built into innovation and entrepreneurial bases for biomedicine and biotechnology. Essence

From the province of the biomedical industry to the strong province, Henan will go further

With the approval of Azf's fixed film, the high -quality development of the Henan biomedical industry has opened a new page. However, in the interview, many talents in the industry proposed that from the provinces of the biomedical industry to strong provinces, Henan needs to go further.

Throughout the development law of the biomedical industry in the country, Wang Yunlong analyzed in -depth analysis, "Henan also lacks medium- and long -term development planning and system policy support, has not established long -term coordination institutions, and has short -term medical research platforms, industry leaders and leading enterprises in terms of shortcomings. plate". Wang Yunlong admits that Henan's blood products, vaccines, antibiotics and other categories of drugs are leading the country, but they lack core companies with leading sheep in the industry. The company's competitiveness is not strong enough, and there is no national, leading brand.

"Henan biomedical industry needs to be strengthened in terms of talent, especially high -end talents with strong R & D capabilities." As a member of the Public Party Central Medical Committee, Zhang Yi, chairman of Yisheng Pharmaceutical, told reporters that compared with other manufacturing companies, The demand for high -end talents in the biomedical industry is more obvious. They must have a forward -looking vision and innovative thinking, and can make good medicines or products. "Now the whole country is robbing talents, it is critical to be able to recruit and keep the talents."

In short, in fact, in fact, Henan has opened the "accelerated running" model in the development of the biomedical industry. Zhengzhou, Luoyang, Anyang and other places have formulated plans and launched corresponding measures.

"We have launched 10 support policies and are expected to invest about 70 million yuan in financial funds. In the next three years, through many aspects such as optimizing spatial layout, innovative financial support, and strengthening talent support, we will strongly support the development of the biomedical industry in Zhengzhou. Zhang Hai, director of the Food Industry Office of Zhengzhou Industry and Information Technology Bureau, introduced that, in order to encourage enterprises to enhance the ability of medical innovation, Zhengzhou provides enterprises that give biological products (prevention and treatment), chemical drugs and Chinese medicine. 10,000 yuan of one -time rewards; enterprises that obtain new drug certificates or production approval will give 5 million yuan of one -time rewards.

The reporter learned that in order to help the biomedical industry optimize and upgrade, the "Henan Province Promoting Implementation Plan for Biological Economic Development" was officially released recently. That is, Zhengzhou and Xinxiang's joint development of the biological economic core areas, the "five bases", which are five biological economic bases including Luoyang, Puyang, Nanyang, Shangqiu, Zhoukou.

- END -